2024-09-19 - Analysis Report
## UnitedHealth Group Inc. (UNH) Stock Analysis

**Company Overview:** UnitedHealth Group Inc. is a leading health care and insurance company in the United States, providing a wide range of health care products and services. 

**Performance Analysis:**

* **Return:** UNH has a cumulative return of 297.4, significantly outperforming the S&P 500 (VOO) with a cumulative return of 129.06. The relative outperformance is 68.27% compared to the historical range of 0 to 231.77.

* **Price Movement:**
    * **Closing price:** 579.83
    * **5-day Moving Average:** 588.29
    * **20-day Moving Average:** 589.83
    * **60-day Moving Average:** 557.6
    * **Analysis:** The stock is trading below its 5 and 20-day moving averages, suggesting potential for short-term downward pressure. However, the 60-day moving average indicates strong upward trend over a longer period.

* **Technical Indicators:**
    * **RSI:** 44.5. This suggests the stock is in a neutral territory, neither overbought nor oversold.
    * **PPO:** -0.49. This indicates a slightly bearish sentiment, with the price lagging behind the moving average.
    * **Delta_Previous_Relative_Divergence:** -0.35. This indicates a recent short-term downward trend in the stock's relative performance compared to the market.
    * **Expected Return:** 78.24%. This represents the potential maximum return on investment over the next five years based on current data.

* **Earnings:**
    | Date | EPS | Revenue |
    |---|---|---|
    | 2024-08-09 | 4.58 | 98.86 B$ |
    | 2024-05-09 | -1.53 | 99.80 B$ |
    | 2023-11-06 | 6.31 | 92.36 B$ |
    | 2023-08-02 | 5.89 | 92.90 B$ |
    | 2024-08-09 | 5.89 | 92.90 B$ |

    * **Analysis:** The company has shown consistent revenue growth with minor fluctuations in EPS. The latest earnings report (2024-08-09) exceeded expectations, indicating strong performance.

**Overall Analysis:**

UNH has consistently outperformed the broader market with strong returns and consistent revenue growth. Despite some short-term downward pressure, the long-term outlook remains positive. The company's robust earnings, coupled with its leading market position, contribute to its overall strong performance. The technical indicators suggest potential for short-term volatility, however, the stock's fundamental strength suggests a long-term growth potential.  The company's financial stability and strong market presence position it well for continued success in the healthcare sector. 
